Commission Implementing Decision (EU) 2016/423 of 18 March 2016 authorising certain laboratories in Egypt, the United Arab Emirates and the United States to carry out serological tests to monitor the effectiveness of rabies vaccines in dogs, cats and ferrets (notified under document C(2016) 1609) (Text with EEA relevance)

In accordance with Article 3(2) of Decision 2000/258/EC, the following laboratories are hereby authorised to perform serological tests to monitor the effectiveness of rabies vaccines in dogs, cats and ferrets: (a) Animal Health Research Institute 7 Nadi El-Said Street P.O. Box 12618 Dokki Giza Egypt (b) Central Veterinary Research Laboratory PO Box 597 Dubai United Arab Emirates (c) Atlanta Health Associates Rabies Laboratory 309 Pirkle Ferry Road, Suite D300, Cumming, GA 30040, United States of America (d) Auburn University College of Veterinary Medicine Department of Pathobiology, Virology Laboratory 261 Greene Hall Auburn, AL 36849 United States of America (e) Centers for Disease Control and Prevention Rabies Laboratory 1600 Clifton Road, NE Atlanta, GA 30333 United States of America

This Decision shall apply from 15 April 2016.

This Decision is addressed to the Member States.